Safety and Efficacy of Microwave Ablation of Stage T1 Renal Cell Carcinoma

Abstract

questionnaire replies (out of 73 PMT patients) were included in this study (41% return rate). 24/29 patients (83%) suffered from no or mild PTS symptoms, while the overall mean VEINES Sym/ QoL scores were 75% and 76%, respectively. Direct correlation between the poorer PTS and VEINES Sym/QoL scores was observed. No statistically significant difference was seen between patients who were treated with/without stenting and compression stockings, neither their body mass index nor gender. Conclusion: There is a positive outcome in the symptoms of PTS and QoL among IF-DVT patients treated with PMT at long-term followup. Hence, PMT should be considered in this cohort. Improved patient selection factors targeting the most at-risk group should be further investigated.